Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Both companies now aim to win in the oral weight loss drug market.

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...